Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Giulia Lanzilli"'
Autor:
Giuseppe Sconocchia, Sara Caratelli, Tommaso Sconocchia, Roberto Arriga, Andrea Coppola, Giulia Lanzilli, Davide Lauro, Adriano Venditti, Maria Ilaria Del Principe, Francesco Buccisano, Luca Maurillo, Soldano Ferrone
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
For many years, disappointing results have been generated by many investigations, which have utilized a variety of immunologic strategies to enhance the ability of a patient’s immune system to recognize and eliminate malignant cells. However, in re
Externí odkaz:
https://doaj.org/article/1d258a6762934cae8ffb083a304d583f
Autor:
M. Gabriella Santoro, Antonio Rossi, Marta Coccia, Giulia Lanzilli, Silvia Santopolo, Anna Riccio, Sofia Pizzato Scomazzon
Supplementary Table 1. Primers and siRNAs used. Supplementary Table 2. Antibodies used. Supplementary Figure S1. Effect of different proteasome inhibitors on AIRAP expression in M10 melanoma cells. Supplementary Figure S2. Intracellular localization
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4a1ba282a0cf25c8e7addbeedbbc087
https://doi.org/10.1158/1541-7786.22515559
https://doi.org/10.1158/1541-7786.22515559
Autor:
M. Gabriella Santoro, Antonio Rossi, Marta Coccia, Giulia Lanzilli, Silvia Santopolo, Anna Riccio, Sofia Pizzato Scomazzon
The zinc-finger AN1-type domain-2a gene, also known as AIRAP (arsenite-inducible RNA-associated protein), was initially described as an arsenite-inducible gene in Caenorhabditis elegans and mammalian cells. Differently from the AIRAP worm homologue,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b3a81a6980e898e4c33dc00a973510d
https://doi.org/10.1158/1541-7786.c.6541123
https://doi.org/10.1158/1541-7786.c.6541123
Autor:
Giuseppe Sconocchia, Giulia Lanzilli, Valeriana Cesarini, Domenico A Silvestris, Katayoun Rezvani, Roberto Arriga, Sara Caratelli, Ken Chen, Jinzhuang Dou, Carlo Cenciarelli, Gabriele Toietta, Silvia Baldari, Tommaso Sconocchia, Francesca De Paolis, Anna Aureli, Giandomenica Iezzi, Maria Irno Consalvo, Francesco Buccisano, Maria I del Principe, Luca Maurillo, Adriano Venditti, Alessio Ottaviani, Giulio C Spagnoli
The FcγRII (CD32) ligands are IgFc fragments and pentraxins. The existence of additional ligands is unknown. We engineered T cells with human chimeric receptors resulting from the fusion between CD32 extracellular portion and transmembrane CD8α lin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7d94e7643368932ed25648cf607c3be
https://hdl.handle.net/2108/307175
https://hdl.handle.net/2108/307175
Autor:
Silvia Santopolo, Anna Riccio, M. Gabriella Santoro, Marta Coccia, Giulia Lanzilli, Sofia Pizzato Scomazzon, Antonio Rossi
Publikováno v:
Molecular cancer research (Online) 17 (2019): 2444–2456. doi:10.1158/1541-7786.MCR-19-0243
info:cnr-pdr/source/autori:Pizzato Scomazzon S.; Riccio A.; Santopolo S.; Lanzilli G.; Coccia M.; Rossi A.; Santoro M.G./titolo:The Zinc-Finger AN1-Type Domain 2a Gene Acts as a Regulator of Cell Survival in Human Melanoma: Role of E3-Ligase cIAP2/doi:10.1158%2F1541-7786.MCR-19-0243/rivista:Molecular cancer research (Online)/anno:2019/pagina_da:2444/pagina_a:2456/intervallo_pagine:2444–2456/volume:17
info:cnr-pdr/source/autori:Pizzato Scomazzon S.; Riccio A.; Santopolo S.; Lanzilli G.; Coccia M.; Rossi A.; Santoro M.G./titolo:The Zinc-Finger AN1-Type Domain 2a Gene Acts as a Regulator of Cell Survival in Human Melanoma: Role of E3-Ligase cIAP2/doi:10.1158%2F1541-7786.MCR-19-0243/rivista:Molecular cancer research (Online)/anno:2019/pagina_da:2444/pagina_a:2456/intervallo_pagine:2444–2456/volume:17
The zinc-finger AN1-type domain-2a gene, also known as AIRAP (arsenite-inducible RNA-associated protein), was initially described as an arsenite-inducible gene in Caenorhabditis elegans and mammalian cells. Differently from the AIRAP worm homologue,
Autor:
Giuseppe Sconocchia, Giulia Lanzilli, Valeriana Cesarini, Domenico Alessandro Silvestris, Roberto Arriga, Katayoun Rezvani, Sara Caratelli, Ken Chen, Jinzhuang Dou, Carlo Cenciarelli, Gabriele Toietta, Silvia Baldari, Tommaso Sconocchia, Francesca De Paolis, Anna Aureli, Giandomenica Iezzi, Maria Ilaria del Principe, Adriano Venditti, Alessio Ottaviani, Giulio Cesare Spagnoli
Fcγ RIIA (CD32A) and their ligands, including the immunoglobulin Fc fragment and pentraxins, are key players in a variety of innate immune responses. Still unclear is whether additional ligands of CD32A do exist. The objective of this study is to de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13c23d5afee5c8403df473be3871f31a
https://doi.org/10.1101/2021.12.22.473841
https://doi.org/10.1101/2021.12.22.473841
Acquirer’s corporate reputation in cross-border acquisitions: the moderating effect of country image
Publikováno v:
Journal of Product & Brand Management. 27:858-870
Purpose The purpose of this paper is to investigate whether, in the context of a cross-border acquisition, the acquirer’s country image (CI) could moderate the relationship between the acquirer’s corporate reputation (CR) and consumers’ repurch
Autor:
Giuseppe Pannone, Corrado Rubini, Andrea Cottarelli, Giuseppe Angelico, Saveria Spadola, Romina Rocchetti, Lorenzo Lo Muzio, Salvatore De Maria, Gian Franco Zannoni, Angela Santoro, Giulia Lanzilli, Maria Carmela Pedicillo, Monica Emanuelli, Paola Stiuso, Maria Pia Fuggetta
Publikováno v:
APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. Supplementum (2020). doi:10.1111/apm.13078
info:cnr-pdr/source/autori:Salvatore De Maria, Maria Pia Fuggetta, Romina Rocchetti, Andrea Cottarelli, Giulia Lanzilli, Paola Stiuso, Angela Santoro, Giuseppe Angelico, Saveria Spadola, Gian Franco Zannoni, Corrado Rubini, Monica Emanuelli, Giuseppe Pannone, Lorenzo Lo Muzio/titolo:A possible interplay between HR-HPV and stemness in tumor development: An in vivo investigation of CD133 as a putative marker of cancer stem cell in HPV18 infected kb cell-line/doi:10.1111%2Fapm.13078/rivista:APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. Supplementum/anno:2020/pagina_da:/pagina_a:/intervallo_pagine:/volume
info:cnr-pdr/source/autori:Salvatore De Maria, Maria Pia Fuggetta, Romina Rocchetti, Andrea Cottarelli, Giulia Lanzilli, Paola Stiuso, Angela Santoro, Giuseppe Angelico, Saveria Spadola, Gian Franco Zannoni, Corrado Rubini, Monica Emanuelli, Giuseppe Pannone, Lorenzo Lo Muzio/titolo:A possible interplay between HR-HPV and stemness in tumor development: An in vivo investigation of CD133 as a putative marker of cancer stem cell in HPV18 infected kb cell-line/doi:10.1111%2Fapm.13078/rivista:APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. Supplementum/anno:2020/pagina_da:/pagina_a:/intervallo_pagine:/volume
Background: High risk HPVs (HR-HPVs) are DNA viruses considered as primary etiologic factors in malignancies of the low female genital tract. Their presence has also been documented in oropharyngeal and laryngeal cancers. However, HPV infection is co
Autor:
Giuseppe Sconocchia, Davide Lauro, Roberto Arriga, Soldano Ferrone, Sara Caratelli, Giandomenica Iezzi, Mario Roselli, Tommaso Sconocchia, Alessio Ottaviani, Gianpietro Dotti, Giulio C. Spagnoli, Andrea Coppola, Giulia Lanzilli, Carlo Cenciarelli
Publikováno v:
Int J Cancer
International journal of cancer (Online) (2019). doi:10.1002/ijc.32618
info:cnr-pdr/source/autori:1 Arriga, Roberto; 2 Caratelli, Sara; 2 Lanzilli, Giulia; 2 Ottaviani, Alessio; 2 Cenciarelli, Carlo; 3 Sconocchia, Tommaso; 2 Spagnoli, Giulio C.; 4 Iezzi, Giandomenica; 1 Roselli, Mario; 1 Lauro, Davide; 1 Coppola, Andrea; 5 Dotti, Gianpietro; 6 Ferrone, Soldano; 2 Sconocchia, Giuseppe/titolo:CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximab/doi:10.1002%2Fijc.32618/rivista:International journal of cancer (Online)/anno:2019/pagina_da:/pagina_a:/intervallo_pagine:/volume
International journal of cancer (Online) (2019). doi:10.1002/ijc.32618
info:cnr-pdr/source/autori:1 Arriga, Roberto; 2 Caratelli, Sara; 2 Lanzilli, Giulia; 2 Ottaviani, Alessio; 2 Cenciarelli, Carlo; 3 Sconocchia, Tommaso; 2 Spagnoli, Giulio C.; 4 Iezzi, Giandomenica; 1 Roselli, Mario; 1 Lauro, Davide; 1 Coppola, Andrea; 5 Dotti, Gianpietro; 6 Ferrone, Soldano; 2 Sconocchia, Giuseppe/titolo:CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximab/doi:10.1002%2Fijc.32618/rivista:International journal of cancer (Online)/anno:2019/pagina_da:/pagina_a:/intervallo_pagine:/volume
KRAS mutations hinder therapeutic efficacy of epidermal growth factor receptor (EGFR)-specific monoclonal antibodies cetuximab and panitumumab-based immunotherapy of EGFR+ cancers. Although cetuximab inhibits KRAS-mutated cancer cell growth in vitro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc87c65724ea6b261df04062aa3098c3
Autor:
Carlo Cenciarelli, Giuseppe Sconocchia, Giulia Lanzilli, Thomas Caceci, Roberto Arriga, Hany E. Marei, Asma Althani, Alessio Ottaviani, Mario Roselli, Tommaso Sconocchia, Sara Caratelli
Publikováno v:
Biochemical pharmacology 166 (2019): 335–346. doi:10.1016/j.bcp.2019.06.002
info:cnr-pdr/source/autori:Hany E. Marei 1, Asma Althani 2, Thomas Caceci 3, Roberto Arriga 4, Tommaso Sconocchia 5, Alessio Ottaviani 6, Giulia Lanzilli 6, Mario Roselli 4, Sara Caratelli 6, Carlo Cenciarelli 6*, Giuseppe Sconocchia 6*/titolo:Recent perspective on CAR and Fcgamma-CR T cell immunotherapy for cancers: Preclinical evidence versus clinical outcomes/doi:10.1016%2Fj.bcp.2019.06.002/rivista:Biochemical pharmacology/anno:2019/pagina_da:335/pagina_a:346/intervallo_pagine:335–346/volume:166
info:cnr-pdr/source/autori:Hany E. Marei 1, Asma Althani 2, Thomas Caceci 3, Roberto Arriga 4, Tommaso Sconocchia 5, Alessio Ottaviani 6, Giulia Lanzilli 6, Mario Roselli 4, Sara Caratelli 6, Carlo Cenciarelli 6*, Giuseppe Sconocchia 6*/titolo:Recent perspective on CAR and Fcgamma-CR T cell immunotherapy for cancers: Preclinical evidence versus clinical outcomes/doi:10.1016%2Fj.bcp.2019.06.002/rivista:Biochemical pharmacology/anno:2019/pagina_da:335/pagina_a:346/intervallo_pagine:335–346/volume:166
The chimeric antigen receptor T cell (CAR-T cell) immunotherapy currently represents a hot research trend and it is expected to revolutionize the field of cancer therapy. Promising outcomes have been achieved using CAR-T cell therapy for haematologic